Related Experiment Video
Updated: Apr 19, 2026

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs
Published on: December 24, 2015
[Inhibitory effect of bone marrow mesenchymal stem cells on lymphoma cell proliferation]
A-Peng Yang1, Ling-Tao Tang2, Jun-Min Chen1
1Department of Hematology & Rheumatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian Province, China.
Abstract:
Growing evidences show that mesenchymal stem cells (MSC) home to tumorgenesis and inhibit tumor cells, however, their molecular mechanisms are unclear. The purpose of this study was to explore the effect of B7-H4 in the influence of the mouse MSC on the proliferation of lymphoma cell line EL-4. The expression of B7-H4 on the MSC cell line C3H10T1/2 (C3H10) was detected by using immunofluorescence. FAM-siRNA was synthesized and transfected into C3H10 cells by INTERFER in (TM) siRNA Transfection Reagent. The transfection efficiency was determined by fluorescent microscopy and flow cytometry. The mRNA expression of B7-H4 was detected by RT-PCR after transfection of siRNA-B7-H4 into C3H10 cell line. The EL-4 was co-cultured with C3H10 siRNA-NC or C3H10 siRNA-B7-H4 for 48 hours, then was compared with EL-4 cultured alone, after 48 hours the cells were harvested under the confocal microscopy and measured by means of CCK-8 Kit. The results showed that the siRNA transfection efficiency in C3H10 cells reached to 72.43%, B7-H4 expressed highly on C3H10, the B7-H4 mRNA expression was down-regulated by transfection with different concentrations of siRNA into C3H10 cells. The proliferation of EL-4 was inhibited by C3H10 cells, and the effects were weakened and even disappeared after down-regulation of B7-H4. It is concluded that C3H10 can inhibit the proliferation of EL-4 through the expression of B7-H4, and this study provides new targets for the clinical treatment of lymphoma.
Insights
Mesenchymal stem cells (MSC) inhibit lymphoma cell proliferation via B7-H4 expression. Down-regulating B7-H4 on MSCs reduced their inhibitory effect on EL-4 lymphoma cells, suggesting B7-H4 as a therapeutic target.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Mesenchymal stem cells (MSC) are known to home to tumors and inhibit cancer cell growth, but the underlying molecular mechanisms remain largely unknown.
- B7-H4 is a molecule implicated in immune regulation and cancer progression.
Purpose of the Study:
- To investigate the role of B7-H4 in the inhibitory effect of mouse MSCs on the proliferation of the EL-4 lymphoma cell line.
- To explore B7-H4 as a potential therapeutic target for lymphoma treatment.
Main Methods:
- B7-H4 expression on C3H10T1/2 (C3H10) MSCs was assessed using immunofluorescence.
- siRNA-mediated knockdown of B7-H4 was performed in C3H10 cells, with transfection efficiency confirmed by microscopy and flow cytometry.
- mRNA levels of B7-H4 were quantified by RT-PCR after siRNA transfection.
- EL-4 cells were co-cultured with B7-H4-silenced C3H10 cells or control cells, and proliferation was measured using the CCK-8 assay.
Main Results:
- High expression of B7-H4 was observed on C3H10 MSCs.
- siRNA transfection successfully down-regulated B7-H4 mRNA expression in C3H10 cells with 72.43% efficiency.
- C3H10 MSCs inhibited EL-4 cell proliferation, an effect that was significantly weakened or abolished when B7-H4 expression was reduced.
Conclusions:
- C3H10 MSCs inhibit EL-4 lymphoma cell proliferation through the expression of B7-H4.
- B7-H4 represents a promising molecular target for novel clinical strategies in lymphoma treatment.
Related Concept Videos
Mesenchymal Stem Cells
Regulation of Hematopoietic Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

